Form 8-K - Current report:
SEC Accession No. 0001477932-25-002313
Filing Date
2025-04-01
Accepted
2025-04-01 11:35:08
Documents
18
Period of Report
2025-03-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K qron_8k.htm   iXBRL 8-K 29071
2 LETTER qron_ex161.htm EX-16.1 3611
8 qron_ex161img3.jpg GRAPHIC 12725
9 qron_ex161img4.jpg GRAPHIC 1458
  Complete submission text file 0001477932-25-002313.txt   168079

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qron-20250329.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qron-20250329_lab.xml EX-101.LAB 13171
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qron-20250329_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qron-20250329_pre.xml EX-101.PRE 8249
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qron-20250329_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT qron_8k_htm.xml XML 3533
Mailing Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101
Business Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55800 | Film No.: 25797823
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)